Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

The impact of positive cancer family history on the clinical features and outcome of patients with non-small cell lung cancer.

Li N, Shao K, Chen Z, Qiu B, Wang Z, Tan F, Wang J, Tan X, Li B, Xiong M, Zhou F, He J.

Fam Cancer. 2011 Jun;10(2):331-6. doi: 10.1007/s10689-010-9403-0.

PMID:
21104151
2.

[Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].

Pfannschmidt J, Muley T, Hoffmann H, Bülzebruck H, Dienemann H.

Dtsch Med Wochenschr. 2006 Nov 24;131(47):2643-8. German.

PMID:
17109272
4.

Prognostic value of pleural effusion in patients with non-small cell lung cancer.

Sugiura S, Ando Y, Minami H, Ando M, Sakai S, Shimokata K.

Clin Cancer Res. 1997 Jan;3(1):47-50.

5.
6.

p53 mutations and survival in stage I non-small-cell lung cancer: results of a prospective study.

Ahrendt SA, Hu Y, Buta M, McDermott MP, Benoit N, Yang SC, Wu L, Sidransky D.

J Natl Cancer Inst. 2003 Jul 2;95(13):961-70.

PMID:
12837832
7.

An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.

Yovino S, Kwok Y, Krasna M, Bangalore M, Suntharalingam M.

Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1438-43.

PMID:
16029805
8.

Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.

Siegfried JM, Weissfeld LA, Singh-Kaw P, Weyant RJ, Testa JR, Landreneau RJ.

Cancer Res. 1997 Feb 1;57(3):433-9.

9.

The favorable prognostic significance of atelectasis in patients with advanced non-small cell lung cancer: results of a prospective observational study.

Dediu M, Crisan E, Radut M, Tarlea A, Median D, Alexandru A, Vremes G, Gal C.

Lung Cancer. 2009 Feb;63(2):271-6. doi: 10.1016/j.lungcan.2008.05.007.

PMID:
18565617
10.

[Factors predictive of survival after lobectomy for non-small cell lung cancer in Iceland during 1999-2008].

Oskarsdóttir GN, Skúladóttir R, Isaksson HJ, Jónsson S, Thorsteinsson H, Gudbjartsson T.

Laeknabladid. 2010 Apr;96(4):251-7. Icelandic.

PMID:
20339164
11.

EGFR mutations are associated with prognosis but not with the response to front-line chemotherapy in the Chinese patients with advanced non-small cell lung cancer.

Wu M, Zhao J, Song SW, Zhuo M, Wang X, Bai H, Wang S, Yang L, An T, Zhang Y, Duan J, Wang Y, Guo Q, Liu X, Liu N, Wang J.

Lung Cancer. 2010 Mar;67(3):343-7. doi: 10.1016/j.lungcan.2009.04.011.

PMID:
19477549
13.

Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.

De Petris L, Orre LM, Kanter L, Pernemalm M, Koyi H, Lewensohn R, Lehtiö J.

Lung Cancer. 2009 Mar;63(3):410-7. doi: 10.1016/j.lungcan.2008.06.003.

PMID:
18620780
14.

Effect of vascular endothelial growth factor polymorphisms on survival in advanced-stage non-small-cell lung cancer.

Masago K, Fujita S, Kim YH, Hatachi Y, Fukuhara A, Nagai H, Irisa K, Ichikawa M, Mio T, Mishima M.

Cancer Sci. 2009 Oct;100(10):1917-22. doi: 10.1111/j.1349-7006.2009.01253.x.

15.

[Lung cancer in women: clinical features and factors related to survival].

Sen E, Kaya A, Erol S, Savas I, Gonullu U.

Tuberk Toraks. 2008;56(3):266-74. Turkish.

PMID:
18932027
16.

Survival rates and tolerability of platinum-based chemotherapy regimens for elderly patients with non-small-cell lung cancer (NSCLC).

Costa GJ, Fernandes AL, Pereira JR, Curtis JR, Santoro IL.

Lung Cancer. 2006 Aug;53(2):171-6.

PMID:
16757059
17.

[Analysis of prognostic factors in 1826 patients with completely resected non-small cell lung cancer].

Gao YS, Xing XZ, Shao K, Feng XL, He J.

Zhonghua Zhong Liu Za Zhi. 2008 Feb;30(2):134-7. Chinese.

PMID:
18646698
18.

Biological markers and DNA flow cytometric analysis in radically resected patients with non-small cell lung cancer. A study of the Perugia Multidisciplinary Team for Thoracic Tumors.

Ludovini V, Pistola L, Gregorc V, Floriani I, Rulli E, Di Carlo L, Semeraro A, Daddi G, Darwish S, Stocchi L, Tofanetti FR, Bellezza G, Sidoni A, Tognellini R, Crinò L, Tonato M.

Tumori. 2008 May-Jun;94(3):398-405.

19.

VEGF polymorphisms and survival in early-stage non-small-cell lung cancer.

Heist RS, Zhai R, Liu G, Zhou W, Lin X, Su L, Asomaning K, Lynch TJ, Wain JC, Christiani DC.

J Clin Oncol. 2008 Feb 20;26(6):856-62. doi: 10.1200/JCO.2007.13.5947.

PMID:
18281657
20.

Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.

Huang C, Taki T, Adachi M, Konishi T, Higashiyama M, Miyake M.

Oncogene. 1998 May 14;16(19):2469-77.

Supplemental Content

Support Center